Publicaciones en colaboración con investigadores/as de Hospital Universitari de Tarragona Joan XXIII (41)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia

    International Journal of Antimicrobial Agents, Vol. 64, Núm. 2

2023

  1. Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age

    Antibiotics, Vol. 12, Núm. 2

  2. Cerebral Oximetry Monitoring in Extremely Preterm Infants

    New England Journal of Medicine, Vol. 388, Núm. 16, pp. 1501-1511

  3. The NDDG criteria versus the IADPSG or the ADA criteria for diagnosing early-onset gestational diabetes mellitus or abnormal glucose tolerance

    International Journal of Gynecology and Obstetrics, Vol. 160, Núm. 3, pp. 906-914

  4. Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio

    Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 3, pp. 143-151

2022

  1. Fasting Glucose for the Diagnosis of Gestational Diabetes Mellitus (GDM) during the COVID-19 Pandemic

    Nutrients, Vol. 14, Núm. 16

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  3. Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network

    European Journal of Pediatrics, Vol. 181, Núm. 2, pp. 789-799

2021

  1. Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 11, pp. 2993-3001

  2. Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown

    Frontiers in Pediatrics, Vol. 9

  3. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

    Journal of Pediatrics, Vol. 236, pp. 211-218.e2

  4. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

    AIDS, Vol. 35, Núm. 12, pp. 1973-1985

  5. Neonates born to mothers with COVID-19: Data from the Spanish society of neonatology registry

    Pediatrics, Vol. 147, Núm. 2

  6. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

    Viruses, Vol. 13, Núm. 1

2020

  1. A multicenter national survey of children with SARS-CoV-2 infection admitted to Spanish Pediatric Intensive Care Units

    Intensive Care Medicine

  2. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  4. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain

    Critical care (London, England), Vol. 24, Núm. 1, pp. 666

  5. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1